| scholarly article | Q13442814 |
| P2093 | author name string | G. David | |
| M. Demedts | |||
| E. Verbeken | |||
| G. Deneffe | |||
| K. Nackaerts | |||
| B. Vanderschueren | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome | Q24320198 | ||
| Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon | Q24651622 | ||
| Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans | Q28213234 | ||
| Integral membrane heparan sulfate proteoglycans | Q28262453 | ||
| Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells | Q34448535 | ||
| Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion | Q36220888 | ||
| Developmental changes in heparan sulfate expression: in situ detection with mAbs | Q36532134 | ||
| Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells | Q36810615 | ||
| Heparan sulfate degradation in tumor cell invasion and angiogenesis. | Q38197622 | ||
| Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells | Q40365762 | ||
| Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. | Q40389719 | ||
| Integrin-type extracellular matrix receptors in cancer and inflammation | Q40769921 | ||
| The coordinated regulation of heparan sulfate, syndecans and cell behavior | Q40780342 | ||
| The role of syndecan-1 in malignancies | Q41227341 | ||
| The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices | Q42248769 | ||
| Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis | Q42476789 | ||
| The World Health Organization histological typing of lung tumours. Second edition | Q70301504 | ||
| A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1 | Q71403904 | ||
| Expression of syndecan-1 inhibits cell invasion into type I collagen | Q72108058 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparan sulfate proteoglycans | Q66589633 |
| P304 | page(s) | 335-345 | |
| P577 | publication date | 1997-06-01 | |
| 1997-06-20 | |||
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Heparan sulfate proteoglycan expression in human lung-cancer cells | |
| P478 | volume | 74 |
| Q35612443 | A Heparan Sulfate-Binding Cell Penetrating Peptide for Tumor Targeting and Migration Inhibition. |
| Q35000955 | A novel function of heparan sulfate in the regulation of cell-cell fusion |
| Q47991932 | A sugar fix for bone tumours? |
| Q44267705 | ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. |
| Q89497261 | Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan |
| Q26864839 | Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention |
| Q42048950 | Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion |
| Q35108319 | D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo. |
| Q33927026 | Endogenous Synthesis of n-3 Polyunsaturated Fatty Acids in Fat-1 Mice Is Associated with Increased Mammary Gland and Liver Syndecan-1 |
| Q35826330 | Entry of Human T-Cell Leukemia Virus Type 1 Is Augmented by Heparin Sulfate Proteoglycans Bearing Short Heparin-Like Structures |
| Q73411359 | Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor |
| Q41786499 | GPC5 Gene and Its Related Pathways in Lung Cancer |
| Q34670803 | Glycocalyx of lung epithelial cells |
| Q38366332 | Glycosylation alterations in lung and brain cancer |
| Q36321055 | Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells |
| Q34441253 | Heparan sulfate proteoglycans and cancer. |
| Q28609232 | Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions |
| Q28657828 | Heparan sulfate signaling in cancer |
| Q37698254 | Heparin sensing: blue-chip binding |
| Q37352004 | Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets |
| Q35826221 | Human Metapneumovirus (HMPV) Binding and Infection Are Mediated by Interactions between the HMPV Fusion Protein and Heparan Sulfate |
| Q28138786 | Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection |
| Q40980976 | Immunohistopathological characterizatin of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft |
| Q39599906 | In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids |
| Q39034367 | Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer |
| Q37543699 | Interactions between heparan sulfate and proteins-design and functional implications |
| Q37142788 | Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells |
| Q43548809 | Lectin and proteoglycan histochemistry of Merkel cell carcinomas. |
| Q35230305 | Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway |
| Q35562693 | Perlecan and tumor angiogenesis |
| Q34499215 | Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway |
| Q36940157 | Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells |
| Q35088166 | Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma |
| Q36740664 | Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas |
| Q35285294 | Prognostic significance of syndecan-1 expression in cervical cancers |
| Q28278555 | Prostate cancer and the met hepatocyte growth factor receptor |
| Q37475741 | Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. |
| Q34706643 | Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. |
| Q36787608 | Proteoglycans in cancer biology, tumour microenvironment and angiogenesis |
| Q37986399 | Proteoglycans in prostate cancer |
| Q43777017 | Reduced Expression of Syndecan‐1 Affects Metastatic Potential and Clinical Outcome in Patients with Colorectal Cancer |
| Q39494666 | Sdc1 negatively modulates carcinoma cell motility and invasion |
| Q42317502 | Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer. |
| Q47642764 | Syndecan-1 controls lung tumorigenesis by regulating microRNAs packaged in exosomes |
| Q42457370 | Syndecan-1 expression in locally invasive and metastatic prostate cancer |
| Q57767952 | Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers |
| Q39819143 | Syndecan-2 regulates the migratory potential of melanoma cells. |
| Q38189392 | Syndecans as modulators and potential pharmacological targets in cancer progression |
| Q24807364 | Syndecans in tumor cell adhesion and signaling |
| Q24564355 | The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer |
| Q33354119 | The mutual impact of syndecan-1 and its glycosaminoglycan chains--a multivariable puzzle |
| Q90673394 | The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer |
| Q24298247 | pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release |
Search more.